{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:23:42Z","timestamp":1761593022541,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ncl.2025.05.009","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:48:59Z","timestamp":1756813739000},"page":"637-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Laboratory Evaluation of Peripheral Neuropathy"],"prefix":"10.1016","volume":"43","author":[{"given":"David S.","family":"Saperstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd D.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2025.05.009_bib1","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(04)16508-2","article-title":"Peripheral neuropathy","volume":"363","author":"England","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2025.05.009_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3122\/jabfm.17.5.309","article-title":"The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients","volume":"17","author":"Mold","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.ncl.2025.05.009_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","article-title":"The epidemiology and risk factors of chronic polyneuropathy","volume":"31","author":"Hanewinckel","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ncl.2025.05.009_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archneur.56.5.540","article-title":"Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics","volume":"56","author":"Wolfe","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2025.05.009_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/mus.24969","article-title":"Causes of neuropathy in patients referred as \u201cidiopathic neuropathy\u201d","volume":"53","author":"Farhad","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.009_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.17161\/rrnmf.v5i1.21510","article-title":"Pattern recognition of neuropathy and neuronopathy: 7 Questions\/11 Patterns","volume":"5","author":"Barohn","year":"2024","journal-title":"RRNMF Neuromuscular J"},{"key":"10.1016\/j.ncl.2025.05.009_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2008-1040866","article-title":"Cryptogenic sensory and sensorimotor polyneuropathies","volume":"18","author":"Wolfe","year":"1998","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ncl.2025.05.009_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mus.27086","article-title":"Metabolic syndrome and peripheral neuropathy","volume":"63","author":"Kazamel","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.009_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/01.wnl.0000336370.51010.a1","article-title":"Practice parameter: evaluation of distal symmetric sensory polyneuropathy: role of laboratory and genetic testing (an evidence based review)","volume":"72","author":"England","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.009_bib10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.60.9.1296","article-title":"Challenges in the identification of cobalamin-deficiency polyneuropathy","volume":"60","author":"Saperstein","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2025.05.009_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group Guidelines for serum free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispensieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ncl.2025.05.009_bib12","first-page":"75","article-title":"Laboratory testing in peripheral nerve disorders","volume":"5","author":"Levine","year":"2024","journal-title":"RRNMF Neuromuscular Journal"},{"key":"10.1016\/j.ncl.2025.05.009_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.17161\/rrnmf.v1i4.13837","article-title":"A proposed taxonmy of Isolated small fiber neuropathy","author":"Levine","year":"2020","journal-title":"RRNMF Neuromuscular Journal"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.009_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ncl.2020.04.001","article-title":"Small fiber neuropathy","volume":"38","author":"Saperstein","year":"2020","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2025.05.009_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/ene.13508","article-title":"Associated conditions in small fiber neuropathy - a large cohort study and review of the literature","volume":"25","author":"de Greef","year":"2018","journal-title":"Eur J Neurol"},{"issue":"Suppl","key":"10.1016\/j.ncl.2025.05.009_bib16","article-title":"Are fleeting paresthesias due to anxiety or small fiber neuropathy? A reappraisal using skin biopsy","volume":"70","author":"Wojcicka","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.009_bib17","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/brain\/awn093","article-title":"The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology","volume":"131","author":"Devigili","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.009_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/00207454.2012.723652","article-title":"Usefulness of skin biopsies in the evaluation and management of patients with suspected small fiber neuropathy","volume":"123","author":"Saperstein","year":"2013","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.ncl.2025.05.009_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/mus.26648","article-title":"Longitudinal follow-up of biopsy-proven small fiber neuropathy","volume":"60","author":"MacDonald","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.009_bib20","doi-asserted-by":"crossref","first-page":"e2534","DOI":"10.1212\/WNL.0000000000011919","article-title":"Intravenous immunoglobulin therapy in patients with painful idiopathic small fiber neuropathy","volume":"96","author":"Geerts","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.009_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.26748","article-title":"Cryptogenic small-fiber neuropathies: serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3","volume":"61","author":"Levine","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.009_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/CND.0000000000000355","article-title":"Clinical features and treatment response in immune-mediated small fiber neuropathy with trisulfated heparin disaccharide or fibroblast growth factor receptor 3 antibodies","volume":"22","author":"Zeidman","year":"2022","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.ncl.2025.05.009_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/CND.0000000000000485","article-title":"Effectiveness of IVIG on non-length-dependent skin biopsies in small fiber neuropathy with Plexin D1, trisulfated heparin disaccharide, and fibroblast growth factor receptor 3 autoantibodies","volume":"25","author":"Zeidman","year":"2024","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.ncl.2025.05.009_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.27745","article-title":"A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies","volume":"67","author":"Gibbons","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.009_bib25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1161::AID-MUS12>3.0.CO;2-Y","article-title":"Isolated vitamin E deficiency","volume":"19","author":"Jackson","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.009_bib26","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1212\/WNL.61.6.873","article-title":"Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjogren\u2019s syndrome","volume":"61","author":"Wolfe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.009_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jnnp-2019-321849","article-title":"Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies","volume":"91","author":"Tholance","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2025.05.009_bib28","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/ene.14180","article-title":"Clinical characteristics of fibroblast growth factor receptor 3 antibody-related polyneuropathy: a retrospective study","volume":"27","author":"Kovvuru","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2025.05.009_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2025.05.009_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetrical neuropathy","volume":"54","author":"Katz","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.009_bib31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1212\/WNL.48.3.700","article-title":"Electrophysiologic findings in multifocal motor neuropathy","volume":"48","author":"Katz","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2025.05.009_bib32","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1212\/01.CON.0000455883.91426.12","article-title":"Acquired immune demyelinating neuropathies","volume":"20","author":"Dimachkie","year":"2014","journal-title":"Continuum"},{"key":"10.1016\/j.ncl.2025.05.009_bib33","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/WCO.0000000000001087","article-title":"Hereditary motor neuropathies","volume":"35","author":"Frasquet","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2025.05.009_bib34","first-page":"15","article-title":"Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice","volume":"1","author":"Loser","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.ncl.2025.05.009_bib35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ncl.2020.03.010","article-title":"Diabetic lumbosacral radiculoplexus neuropathy (diabetic amyotrophy)","volume":"38","author":"Glenn","year":"2020","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2025.05.009_bib36","series-title":"Peripheral neuropathy","first-page":"2051","article-title":"Polyneuropathy due to nutritional and vitamin deficiency","author":"Saperstein","year":"2005"},{"key":"10.1016\/j.ncl.2025.05.009_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0733-8619(18)30204-4","article-title":"Peripheral neuropathies associated with human immunodeficiency virus infection","volume":"10","author":"Simpson","year":"1992","journal-title":"Neurol Clin"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:20:26Z","timestamp":1761592826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861925000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0733861925000283"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2025.05.009","relation":{},"ISSN":["0733-8619"],"issn-type":[{"type":"print","value":"0733-8619"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory Evaluation of Peripheral Neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2025.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}